\
&
Contact us
\
&
Contact us
This was 4 years ago
Locationvirtual
ProgrammesThe European Commission organises the European Research and Innovation Days 2021 edition on 23 and 24 June. Since 2019 this event brings together policymakers, researchers, entrepreneurs and the public to discuss research and innovation in Europe and beyond.
The preliminary programme has been made available on the event website. Any developments in the run up to the event can be found there. In case you would like to receive regular updates in your mailbox you can subscribe to their newsletter. Updates will be made available also via the Twitter and Facebook account of Directorate-General for Research and Innovation of the European Commission @EUScienceInnov #RiDaysEU. Information on how to participate in the event can be found in the Q&A.
Registration to the event is open from 26 May onwards through this link.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
